Sign up to save your podcasts
Or
Share Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
We love to hear from our listeners. Send us a message.
Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
More shows like Cell & Gene: The Podcast
View all
Fareed Zakaria GPS
3,455 Listeners
Nature Podcast
767 Listeners
HBR IdeaCast
169 Listeners
Science Magazine Podcast
826 Listeners
The Daily
112,482 Listeners
Today, Explained
10,235 Listeners
The Readout Loud
323 Listeners
Short Wave
6,562 Listeners
The Prof G Pod with Scott Galloway
5,554 Listeners
Consider This from NPR
6,421 Listeners
Business Of Biotech
85 Listeners
Hard Fork
5,529 Listeners
The Weekly Show with Jon Stewart
10,391 Listeners
ASGCT Podcast Network
16 Listeners
Prof G Markets
1,425 Listeners